Valuation: GENFIT

Market Cap 705M 824M 658M 604M 1.13B 78.83B 1.16B 7.81B 3.04B 39.5B 3.09B 3.03B 131B P/E 2026 *
36.4x
P/E 2027 * 93.6x
Enterprise Value 654M 764M 610M 560M 1.05B 73.11B 1.07B 7.24B 2.82B 36.64B 2.87B 2.81B 121B EV / Sales 2026 *
6.53x
EV / Sales 2027 * 5.15x
Free-Float
86.89%
Yield 2026 *
-
Yield 2027 * -
1 day-2.08%
1 week+7.47%
Current month-3.82%
1 month+9.30%
3 months+65.88%
6 months+73.22%
Current year+167.81%
1 week 12.96
Extreme 12.96
14.82
1 month 12.74
Extreme 12.74
15.48
Current year 5.05
Extreme 5.05
15.48
1 year 3.05
Extreme 3.048
15.48
3 years 2.62
Extreme 2.62
15.48
5 years 2.62
Extreme 2.62
15.48
10 years 2.62
Extreme 2.62
35.65
Manager TitleAgeSince
Chief Executive Officer 58 16/09/2019
Director of Finance/CFO 52 22/04/2021
Chief Tech/Sci/R&D Officer - 27/11/2025
Director TitleAgeSince
Chairman 70 16/06/2017
Director/Board Member 54 15/09/1999
Director/Board Member 58 16/06/2017
Date Insider Type Main position Quantity % Market Cap.
12/7/23 Buy

Director

5,300 0.0106%
7/7/23 Buy

Chief Executive Officer

10,000 0.0201%
7/7/23 Buy

Founder

10,000 0.0201%
Change 5-day change 1-year change 3-year change Capi.($)
-2.08%+7.47%+266.04%+326.63% 840M
+1.14%+3.46%+4.57%+24.14% 50.5B
-1.36%+3.15%+479.46%+614.84% 46.01B
-2.04%+2.82%+18.13%+91.23% 42.85B
+2.72%+5.93%+33.12%+19.66% 41.03B
0.00%-3.91%+17.87%+47.98% 32.02B
+0.72%+2.62%+32.57%+145.37% 16.98B
-1.85%-0.25% - - 17.05B
+3.06%+4.63%+7.40%+35.00% 14.3B
+0.50%+2.49%+83.90%+46.53% 13.84B
Average +0.14%+2.78%+104.79%+150.15% 27.54B
Weighted average by Cap. +0.28%+2.40%+104.66%+153.44%

Financials

2026 *2027 *
Net sales 100M 117M 93.49M 85.78M 161M 11.2B 164M 1.11B 432M 5.61B 439M 430M 18.58B 124M 145M 116M 106M 200M 13.86B 203M 1.37B 535M 6.95B 544M 532M 23B
Net income 22.88M 26.72M 21.35M 19.59M 36.8M 2.56B 37.53M 253M 98.71M 1.28B 100M 98.15M 4.24B 6.8M 7.94M 6.34M 5.82M 10.94M 760M 11.15M 75.27M 29.34M 381M 29.82M 29.17M 1.26B
Net Debt -51.12M -59.7M -47.69M -43.76M -82.23M -5.71B -83.85M -566M -221M -2.86B -224M -219M -9.48B -66.17M -77.29M -61.74M -56.65M -106M -7.4B -109M -732M -286M -3.71B -290M -284M -12.27B
Logo GENFIT
GENFIT is a biopharmaceutical company in late-stage development focused on the discovery and development of innovative therapeutic and diagnostic solutions in the field of liver diseases, particularly of metabolic origin, where unmet medical needs are considerable, in particular due to a lack of approved treatments. GENFIT is a leading innovator in the field of nuclear receptor-based drug discovery with a rich history and a solid scientific heritage spanning nearly two decades. The company has offices in Lille, Paris, Zurich and Cambridge, MA (USA).
Employees
161
Date Price Change Volume
21/08/26 EUR 14.10 -2.08% 307,015
19/08/26 EUR 14.40 +4.96% 410,201
18/08/26 EUR 13.72 -1.15% 203,967
17/08/26 EUR 13.88 +6.61% 404,952
14/08/26 EUR 13.02 -2.54% 137,537
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
14.40EUR
Average target price
15.90EUR
Spread / Average Target
+10.42%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. GNFT Stock